ai

Building Effective Multi-Disease Surveillance Systems

Tonight, I started watching the Oxford Nanopore Technologies London Calling 2024 expert panel on “Building a rapid, targeted, and responsive infectious disease system.”Aaron Pomerantz, the Associate Director of Global Segment Marketing at ONT, helped facilitate the session. Dr. Ines Hassan from the Tony Blair Institute for Global Change started. Hassan helps encourage the development and […]
Read more

Advancements in Precision Oncology: Key Insights from London Calling 2024

Tonight, I continued watching a session from the London Calling 2024 Clinical & Biopharma Day. The expert panel’s title was “Precision oncology: driving better outcomes for patients, health systems, and populations.” Olivier Lucas, the Director of Oncology with Oxford Nanopore Technologies (ONT), moderated the discussion. The audience asked the panelists questions about sensitivity and risk determination. William Stanford from […]
Read more

Current Trends in Precision Oncology for 2024

Tonight, I started watching a new session from the London Calling 2024 Clinical & Biopharma Day. The expert panel’s title was “Precision oncology: driving better outcomes for patients, health systems, and populations.” Olivier Lucas, the Director of Oncology with Oxford Nanopore Technologies (ONT), moderated the discussion. Four speakers began the session with brief introductions. William […]
Read more

Latest EPI2ME Features for Variant Analysis Explained

Matt Parker, the Director of Clinical Bioinformatics Software at Oxford Nanopore Technologies, facilitated the Nanopore Community Meeting Boston 2024 session on variant analysis with EPI2ME. The title of the presentation was “Ultra-rich human data – variant analysis with EPI2ME.” They shared the EPI2ME user interface updates that were recently released. There is a new element […]
Read more

Unlocking Genomic Frontiers: ONT’s Long-Read Sequencing Breakthroughs

Tonight I started watching a longer session from Oxford Nanopore Technologies (ONT) summer programming. “The era of complete genomes, at any scale” was the title of a session Cora Vaher gave. They described how long-read sequencing with ONT has changed sequencing. Vaher stated that “the era of full genomes is coming” because there are many […]
Read more

NanoRay Platform: Autoscaling Resources & Cost-Benefit Analysis of Computational Needs

Sneha Geonka from Stanford University & Princeton presented on “Computational paradigm for scalable ultra-fast, & cost-efficient nanopore sequencing.” Goenka shared a graph showing the turnaround time for sequencing in the clinic. The world record is 7.3 hours at Stanford! To shorten the time to diagnosis, the pipeline included distributed computing and a lot of GPUs: […]
Read more
Press ESC key to close search